NVIDIA Corp. (NVDA)$215.33
Research Snapshot
Static fundamentals, valuation context, and investor signals for NVIDIA Corp. (NVDA).
Valuation
28.7x
EV/FCF, 3.5% FCF yield
Quality
72.4%
ROIC, 44.8% FCF margin
Growth
66.9%
5Y sales (revenue) CAGR
Balance sheet
0.1x
Debt/equity, 3.9x current ratio
Superinvestors
15
Top: Chase Coleman (9.2%)
Strengths to research
- Revenue compounded at 66.9% over five years.
- Free cash flow compounded at 75.4% over five years.
- Return on equity is strong at 76.3%.
- Free cash flow margin is healthy at 44.8%.
Watchouts
- P/E is elevated at 43.9x.
Quality Scorecard
Build-time composite score for NVDA.
Peer Comparison
Target stock against 5 market-cap comparable peers.
| NVDA Target | NVIDIA Corp. | $2.8T | 43.9x | 28.7x | 72.4% | 66.9% | 44.8% | 71.1% | 0.0x | N/A |
| MSFT | Microsoft Corp. | $3.2T | 30.7x | 45.5x | 26.3% | 14.5% | 25.4% | 68.8% | 0.1x | N/A |
| AVGO | Broadcom Inc. | $943.8B | 86.8x | 34.5x | 28.4% | 21.7% | 42.1% | 67.8% | -0.6x | N/A |
| TSM | Taiwan Semiconductor S.A. | $914.9B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ORCL | Oracle Corp. | $418.6B | 44.3x | -1035.2x | 60.8% | 8.0% | -0.7% | N/A | -0.5x | N/A |
| SAP | SAP SE | $353.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for NVDA (annual).
15 superinvestors own NVDA
Current quarter ownership and quarter-over-quarter share changes.
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Chase Coleman Tiger Global Management | 12,011,752 | $2.1B | 9.17% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 4,761,351 | $830M | 8.49% | 0.0% |
| Polen Capital Management Polen Capital Management | 4,104,247 | $716M | 4.95% | 0.0% |
| Lee Ainslie Maverick Capital | 3,174,918 | $554M | 6.44% | 0.0% |
| John Armitage Egerton Capital | 2,675,018 | $467M | 5.18% | 0.0% |
| Jensen Investment Management Jensen Investment Management | 1,632,015 | $285M | 5.61% | 0.0% |
| David Tepper Appaloosa Management | 1,471,500 | $257M | 4.33% | 0.0% |
| Samantha McLemore Patient Capital Management | 711,115 | $124M | 4.62% | 0.0% |
| Daniel Loeb Third Point | 190,000 | $33M | 1.59% | 0.0% |
| Christopher Davis Davis Advisors | 113,556 | $20M | 0.09% | 0.0% |
| Wallace Weitz Weitz Large Cap Equity Fund | 35,000 | $6M | 0.43% | 0.0% |
| Bill Nygren Oakmark Select Fund | 12,468 | $2M | 0.00% | 0.0% |
| David Katz Matrix Asset Advisors | 7,855 | $1M | 0.13% | 0.0% |
| Dodge & Cox Dodge & Cox | 3,400 | $593,000 | 0.00% | 0.0% |
| Torray Funds Torray Funds | 3,055 | $533,000 | 0.08% | 0.0% |